IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine

Vaccine. 2022 Apr 20;40(18):2528-2530. doi: 10.1016/j.vaccine.2022.03.003. Epub 2022 Mar 24.

Authors

Derar H Abdel-Qader¹, Issa Hazza Alkhatatbeh², Wail Hayajneh³, Hassan Annab², Ahmad Z Al Meslamani⁴, Reem A Elmusa⁵

Affiliations

¹ Faculty of Pharmacy & Medical Sciences, University of Petra, Amman, Jordan.
² Nephrology Department, Jordan Hospital, Amman, Jordan.
³ Department of Pediatrics, Saint Louis University, USA.
⁴ AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates. Electronic address: ahmad.almeslamani@aau.ac.ae.
⁵ Department of Pediatrics, Jordan University Hospital, Jordan.

No abstract available

Keywords: COVID-19 vaccine; Kidney disorder; Pfizer.

Publication types

Letter

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Child
Glomerulonephritis, IGA*
Humans

Substances

COVID-19 Vaccines
BNT162 Vaccine